US2025066881A1PendingUtilityA1
Antimicrobial niobium alloy
Assignee: UNIV KING FAHD PET & MINERALSPriority: May 4, 2023Filed: Nov 7, 2024Published: Feb 27, 2025
Est. expiryMay 4, 2043(~16.8 yrs left)· nominal 20-yr term from priority
C22C 1/0458C22F 1/183C22C 14/00
80
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
An antimicrobial alloy includes titanium, niobium, and silver. Further, the antimicrobial alloy includes between 5 and 30 atomic percent niobium, up to 3 atomic percent silver, the remaining atomic percentage is titanium, and the alloy does not include zirconium. The antimicrobial alloy has a predominantly beta-titanium crystal structure and an elasticity modulus ranging from 60 to 85 GPa. A process for manufacturing the antimicrobial alloy. The antimicrobial alloy prepared by the method can be used in bioimplants.
Claims
exact text as granted — not AI-modified1 . An antimicrobial alloy, comprising:
titanium, niobium, and silver; wherein the alloy comprises between 10 and 30 atomic percent niobium, up to 3 atomic percent silver and between 67 and 7 atomic percent titanium, wherein atomic percent is calculated based on the total number of Ti, Nb and Ag atoms; wherein the alloy does not comprise zirconium; and wherein the antimicrobial alloy has at least 51 percent beta-titanium crystal structure, determined by scanning electron microscope image analysis, and an elasticity modulus ranging from 60 to 85 GPa as measured according to ASTM E111, wherein the alloy has a bulk densification percentage, given by the following expression; (ρ ex of uniaxially pressed powder mixture)/(ρ ex of sintered alloy)×100 that ranges from 80.0 to 95.0%, wherein ρ ex is calculated according to the equation
ρ
ex
=
(
a
/
(
a
-
b
)
)
*
(
ρ
L
-
ρ
a
)
+
ρ
a
wherein ρ ex is the measured density of the specimen as measured by a densimeter, ‘a’ and ‘b’ are the weight of the specimen in air and water, respectively, and ‘ρ L ’ and ‘ρ a ’ are the density of water and air, respectively.
2 . (canceled)
3 . The antimicrobial alloy of claim 1 wherein the bulk densification percentage ranges from 89.3 to 89.7%.
4 . (canceled)
5 . The antimicrobial alloy of claim 1 wherein the alloy has a microhardness ranging from 2.692 to 2.742 GP according to ASTM E384.
6 . The antimicrobial alloy of claim 1 wherein the alloy has an elasticity modulus of about 80 GPa as measured according to ASTM E111.
7 . The antimicrobial alloy of claim 1 wherein the alloy has a corrosion potential voltage ranging from −0.130 and −0.150 V as measured using electrochemical impedance spectroscopy in at least one of the group consisting of artificial saliva and simulated body fluid.
8 . (canceled)
9 . The antimicrobial alloy of claim 1 wherein said alloy inhibits gram-positive bacteria growth by at least 85 percent as measured by agar diffusion according to the equation
Inhibition
efficiency
rates
(
%
)
=
(
N
0
-
N
)
/
N
0
×
100
wherein N0 and N represent the average number of colony forming units in control and said alloy-treated samples, respectively.
10 - 16 . (canceled)Join the waitlist — get patent alerts
Track US2025066881A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.